Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation — Stella

Home/Nonvalvular Atrial Fibrillation/

View on ClinicalTrials.gov

Recruiting

Back to Nonvalvular Atrial Fibrillation trials

Trial locations(1 site)

Bosnia and Herzegovina

Clinic for diseases of the heart, blood vessels and rheumatism, Sarajevo

Key details

Sponsor

Bosnalijek D.D

Enrollment target

~800 participants

Started

October 2025

Primary completion

April 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.